Effects of tetraiodothyronine and triiodothyronine on hamster cheek pouch microcirculation.
The aim of the present study was to assess the effects of topically applied triiodothyronine (T(3)) and thyroxine (T(4)) on the arterioles of hamster cheek pouch microcirculation in vivo. Microvessels were visualized using a fluorescent microscopy technique. Topical application of T(3) (3.08, 30.8, 61.5, 307, 615, and 6,150 nM/l) consistently induced dose-dependent dilation of arterioles within 2.0 +/- 0.5 min of administration. The application of T(4) (150, 257, 514, and 5,140 nM/l) caused different dose-dependent effects: dilation at the three lower doses within 16 +/- 2 min and rhythmic diameter changes at the highest dose. Aging of hamsters did not alter the arteriolar responses to T(3) and T(4). T(3)-induced dilation was countered by the inhibition of nitric oxide synthase with N(G)-nitro-L-arginine-methyl ester or N(G)-nitro-L-arginine. Iopanoic acid (IPA), which inhibits types I and II 5'-deiodinase, abolished the dilation elicited by 514 nM T(4) but did not affect T(3)-dependent dilation. 6-Propyl-2-thiouracil (PTU), which inhibits type I 5'-deiodinase only, did not affect the dilation induced by T(4). IPA and PTU did not impair arteriolar dilation induced by acetylcholine or sodium nitroprusside. These results indicate that T(3) induces arteriolar dilation, likely through nitric oxide release. The local conversion of T(4) to T(3) appears to be crucial for the dilation induced by T(4).
Colantuoni
A
A
Dept. of Neuroscience, Federico II University Medical School, Via S. Pansini 5, 80131 Naples, Italy. colantuo@unina.it
Marchiafava
P L
PL
Lapi
D
D
Forini
F S
FS
Iervasi
G
G
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D001160:Arterioles / Q000187:drug effects; D003287:Contrast Media / Q000494:pharmacology; D006224:Cricetinae; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007480:Iopanoic Acid / Q000494:pharmacology; D008297:Male; D008647:Mesocricetus; D009055:Mouth / Q000098:blood supply*; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D019335:Nitroarginine / Q000494:pharmacology; D011441:Propylthiouracil / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects*; D013974:Thyroxine / Q000494:pharmacology*; D014284:Triiodothyronine / Q000494:pharmacology*
D000963:Antimetabolites; D003287:Contrast Media; D004791:Enzyme Inhibitors; D014284:Triiodothyronine; D019335:Nitroarginine; D011441:Propylthiouracil; D019001:Nitric Oxide Synthase; D007480:Iopanoic Acid; D013974:Thyroxine; D019331:NG-Nitroarginine Methyl Ester